Maulina Rifzul, Qomaruddin Mochammad B, Prasetyo Budi, Indawati Rachmah
Department of Midwifery, Institute Technology, Sains and Health RS Dr. Soepraoen, Malang City, East Java, Indonesia.
Department of Health Promotion and Behavioral Sciences, Faculty of Public Health, Airlangga University, Surabaya, East Java, Indonesia.
Iran J Nurs Midwifery Res. 2024 Jul 2;29(3):309-313. doi: 10.4103/ijnmr.ijnmr_358_22. eCollection 2024 May-Jun.
Stunting can be prevented by early detection when the mother is pregnant. Early detection can be carried out by looking for risk factors of stunting during pregnancy so that interventions can be early detected. This study aims to assess complications during pregnancy (disease and infection) and risk factors associated with stunting.
The type of research was observational analytic with a case-control design on 450 mothers who were selected with simple random sampling (150 mothers who have stunting babies aged 0-2 months and 300 mothers who have not stunting babies aged 0-2 months in Malang Regency, Indonesia. This study used secondary data by looking at medical records, namely, laboratory examinations in the mother's book and cohort records at the public health center. This study was conducted from December 2021 to August 2022. Bivariate analysis with Chi-square and multivariate logistic regression was carried out to determine the variables that most influenced the incidence of stunting.
The results of multivariate analysis with logistic regression of maternal complications during pregnancy, which are a risk as a factor causing stunting, are Sexually Transmitted Infections (STIs) (Odds Ratio [OR]: 6.36; 95% Confidence Interval [CI]: 2.97-13.62), coronavirus disease 2019 (COVID-19) accompanied by pneumonia (OR: 5.12; 95% CI: 1.87-14.052), human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (OR: 4.63; 95% CI: 1.10-19.59), hepatitis B (OR: 3.97; 95% CI: 1.253-12.565), pre-eclampsia (OR: 3.88; 95% CI: 1.81-8.30), and heart disease (OR: 3.373; 95% CI: 0.99-11.40).
After recognizing the maternal factors that cause stunting, intervention should immediately be carried out on pregnant women with diseases (pre-eclampsia and heart disease) and infections (STI, COVID-19 + pneumonia, HIV/AIDS, and hepatitis B) to prevent stunting early.
发育迟缓可在母亲孕期通过早期检测得以预防。早期检测可通过查找孕期发育迟缓的风险因素来进行,以便能尽早发现干预措施。本研究旨在评估孕期并发症(疾病和感染)以及与发育迟缓相关的风险因素。
本研究类型为观察性分析,采用病例对照设计,对450名母亲进行简单随机抽样选取(印度尼西亚马朗县150名有0至2个月发育迟缓婴儿的母亲和300名有0至2个月未发育迟缓婴儿的母亲)。本研究通过查看病历使用二手数据,即母亲手册中的实验室检查以及公共卫生中心的队列记录。本研究于2021年12月至2022年8月进行。采用卡方检验和多因素逻辑回归进行双变量分析,以确定对发育迟缓发生率影响最大的变量。
对孕期母亲并发症进行逻辑回归的多因素分析结果显示,作为导致发育迟缓因素的风险因素有性传播感染(STIs)(比值比[OR]:6.36;95%置信区间[CI]:2.97 - 13.62)、伴有肺炎的2019冠状病毒病(COVID - 19)(OR:5.12;95% CI:1.87 - 14.052)、人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)(OR:4.63;95% CI:1.10 - 19.59)、乙型肝炎(OR:3.97;95% CI:1.253 - 12.565)、子痫前期(OR:3.88;95% CI:1.81 - 8.30)以及心脏病(OR:3.373;95% CI:0.99 - 11.40)。
在识别出导致发育迟缓的母亲因素后,应立即对患有疾病(子痫前期和心脏病)和感染(性传播感染、COVID - 19 + 肺炎、HIV/AIDS和乙型肝炎)的孕妇采取干预措施,以尽早预防发育迟缓。